Obesity Management

On the HCPLive Obesity Management condition center page, resources on the topics of medical news and expert insight into clinical weight management can be found. Content includes articles, interviews, videos, podcasts, and breaking news on obesity research, treatment, and drug development.

Latest News

Arun Sanyal, MD | Credit: VCU
Survodutide, a Glucagon/GLP-1 RA, Reduces MASH in Phase 2 Trial

February 26th 2024

Survivodutide, a dual agonist from Boehringer Ingelheim and Zealand Pharma, was associated with MASH resolution without worsening fibrosis among 83% of participants in a phase 2 trial.

Viral N. Shah, MD | Image Credit: University of Colorado School of Medicine
Tirzepatide Significantly Reduces HbA1c, Body Weight in Type 1 Diabetes

February 7th 2024

James A. de Lemos, MD | Credit: UT Southwestern Medical Center
New Study Finds Tirzepatide Use Lowered Blood Pressure in Patients with Obesity

February 5th 2024

Lu Qi, MD, PhD | Image Credit: Tulane University
Improving Social Isolation, Loneliness Reduces Obesity-Related Mortality Risk

January 24th 2024

Tom Yates, PhD | Image Credit: University of Leicester
Weight Cycling Linked to Fat-Free Mass Loss in People At Risk of Diabetes

December 19th 2023

Latest CME Events & Activities

Earn CME Credits While Advancing Your Expertise in Internal Medicine

April 18-19, 2024

Register Now!

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Evaluating the Recent Advancements in Chronic Kidney Disease Treatment: A Case-Based Approach to Managing CKD and Related Comorbidities

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing

View More

Oncology Briefings™: Coordinating the Long-Term Management of Patients With Multiple Myeloma Between Primary Care and Oncology Practices

View More

Advances In™: The Potential Role of Ultra-Long-Acting Basal Insulin Therapies in Type 2 Diabetes

View More

6th Annual Advanced Practice Collaborative

View More

Shaping the Management of COPD with Biologic Therapy

View More

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Cases and Conversations™: Guideline Recommendations for the Use of Basal Insulin Therapy in Type 2 Diabetes

View More

Advances In™ Rare Genetic Forms of Obesity: Emerging Therapeutic Targets

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

View More

Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis

View More

Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD

View More

(CME) Community Practice Connections™: Dry Eye Disease and Novel Tear Stimulating Therapies – Optimizing Outcomes in Patient Sub-Types

View More

(COPE) Community Practice Connections™: Dry Eye Disease and Novel Tear Stimulating Therapies – Optimizing Outcomes in Patient Sub-Types

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

More News

© 2024 MJH Life Sciences

All rights reserved.